240 million vaccine doses expected for the US by end of March --Pharm company testimony

Pharmaceutical companies pledge 240 million vaccine doses for the US by end of March The United States can expect to see a total of 240 million doses of Covid-19 vaccine by the end of March, according to prepared remarks drug companies will deliver to a House subcommittee today. The vaccine makers are set to testify at 10:30 a.m. ET. By <a href="/profiles/helen-regan">Helen Regan</a>, Eoin McSweeney and Ed Upright, CNN CNN

The United States can expect to see a total of 240 million doses of Covid-19 vaccine by the end of March, according to prepared remarks drug companies will deliver to a House subcommittee today. The vaccine makers are set to testify at 10:30 a.m. ET.

Pfizer and Moderna – the two companies with Covid-19 vaccines authorized for emergency use in the United States – have pledged to make a combined total of 220 million doses available for shipment by the end of March. 

Meanwhile, the company Johnson & Johnson, which has yet to receive an emergency use authorization for its Covid-19 vaccine, has pledged to make 20 million doses available in the same time frame.

Each of the vaccine makers, along with the companies AstraZeneca and Novavax, provided prepared remarks ahead of a hearing before the House Committee on Energy and Commerce Subcommittee on Oversight and Investigations on Tuesday. In the remarks, each company detailed the number of doses it plans to provide and when.

Pfizer noted in its remarks that it expects to increase the number of doses available for shipment from about 4 to 5 million doses per week at the beginning of February to more than 13 million doses per week by the middle of March. 

Moderna, the other company with an authorized Covid-19 vaccine, noted in its remarks that it is on track to meet a commitment to deliver 100 million doses by the end of March and it plans to double monthly deliveries by April to more than 40 million doses per month. ...